Mount Sinai Researchers Find New, Safer Treatment for Serious Side Effect of Bone Marrow Transplant
Mount Sinai Health SystemResearchers at The Tisch Cancer Institute at Mount Sinai have identified a treatment that is effective and safer than the standard of care for a serious, and sometimes fatal, side effect of bone marrow transplant in cancer patients. Results from a phase 2 clinical trial were presented at the annual meeting of the American Society of Hematology (ASH) in December.